This is a permanent results page for your analyzed data. Please save the link in your browser's address bar.
| Title / Description | Imatinib mesylate effect on bone marrow hematopoietic cells of chronic myeloid leukemia patients |
| Accession | GDS4869 |
| Summary | Analysis of bone marrow hematopoietic cells in chronic myeloid leukemia (CML) patients one month after imatinib mesylate (IM) therapy. CML is caused by expression of the BCR/ABL fusion oncogene. Results provide insight into the molecular consequences of IM blockade of oncoprotein Bcr-Abl in CML. |
| Organism | Homo sapiens |
| Platform | GPL570 |
| Normalized | False |
| Parsed SOFT file |
| Differential expression method | Characteristic Direction |
| Cutoff | 500 |
| Cell | Bone marrow |
| Perturbation | Imatinib |
| Disease | Chronic myeloid leukemia |
| Principal Component Analysis | |
| Hierarchical clustering |
| Gene lists | Enrichr | L1000CDS2 | PAEA | |
| Up |
|
|||
| Down |
|
|||
| Combined |
|
|
|
